increased heart rate on semaglutide GLP-1 Agonists and Why Does GLP-1 Increase Heart
Description
Annual initiation prevalence was calculated for each eligible BMI subgroup
From January to June 2025, AOM tirzepatide prescribing increased steadily (+0.09 percentage points per month)
However, understanding the potential causes can help you implement effective approaches to reduce their occurrence and distinguish between expected medication effects and symptoms requiring medical attention
Improvements in anxiety, depression, and a reductions in suicidal ideation and suicide attempts appear substantial
What to expect after first semaglutide injection is a common concern for patients beginning this GLP-1 medication for type 2 diabetes or weight management
